(0.07%) 5 158.25 points
(0.08%) 38 862 points
(-0.03%) 17 996 points
(0.38%) $78.41
(0.56%) $2.15
(0.40%) $2 317.90
(1.73%) $27.15
(-0.25%) $962.90
(0.03%) $0.929
(-0.14%) $10.86
(0.01%) $0.797
(0.05%) $91.50
-3.94% $ 1.220
Live Chart Being Loaded With Signals
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer...
Stats | |
---|---|
Dzisiejszy wolumen | 23 507.00 |
Średni wolumen | 38 611.00 |
Kapitalizacja rynkowa | 29.22M |
EPS | $0 ( 2024-03-28 ) |
Następna data zysków | ( $-0.140 ) 2024-05-13 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.230 |
ATR14 | $0.0180 (1.46%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-06 | Gentry Leesa | Buy | 190 000 | Options |
2023-06-01 | Gentry Leesa | Sell | 62 500 | Options |
2024-01-19 | Gentry Leesa | Sell | 60 159 | Options |
2024-02-09 | Kocak Ron | Buy | 15 000 | Options |
2022-08-18 | Kocak Ron | Sell | 34 390 | Options |
INSIDER POWER |
---|
70.96 |
Last 81 transactions |
Buy: 2 293 038 | Sell: 2 003 949 |
RenovoRx, Inc. Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
ALTR | 0.934 |
DUOL | 0.93 |
OVLY | 0.925 |
SVFAU | 0.921 |
BIOT | 0.92 |
APXI | 0.918 |
RAM | 0.917 |
ANSS | 0.916 |
LCAA | 0.914 |
OTEC | 0.913 |
10 Najbardziej negatywne korelacje | |
---|---|
CBNK | -0.923 |
GOOD | -0.917 |
BWB | -0.916 |
GSMG | -0.915 |
ALRS | -0.911 |
CSSEP | -0.909 |
AROW | -0.909 |
GNTY | -0.908 |
FGBI | -0.906 |
JAGX | -0.905 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
RenovoRx, Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.990 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $0 (0.00 %) |
EPS: | $-0.990 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-6 000.00 (0.00 %) |
EPS: | $-1.080 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.754 |
Financial Reports:
No articles found.
RenovoRx, Inc.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej